Indication and benefit of upfront hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma in the era of ALL-type induction therapies

Since the introduction of leukemia-type induction therapies for T-cell lymphoblastic lymphoma (T-LBL), improvements in the long-term outcomes of T-LBL have been reported. However, indications for and the appropriate timing of hematopoietic stem cell transplantation (HSCT) have not yet been establish...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita-Fujita, Mari, Arai, Yasuyuki, Yoshioka, Satoshi, Ishikawa, Takayuki, Kanda, Junya, Kondo, Tadakazu, Akasaka, Takashi, Ueda, Yasunori, Imada, Kazunori, Moriguchi, Toshinori, Yago, Kazuhiro, Kitano, Toshiyuki, Yonezawa, Akihito, Nohgawa, Masaharu, Takaori-Kondo, Akifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722931/
https://www.ncbi.nlm.nih.gov/pubmed/33293600
http://dx.doi.org/10.1038/s41598-020-78334-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722931/
https://www.ncbi.nlm.nih.gov/pubmed/33293600
http://dx.doi.org/10.1038/s41598-020-78334-x

Ejemplares similares